Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015-2017): A multicentre prospective study.
- DOI
- 10.1016/j.lanwpc.2022.100452
- Published
- 2022 Jun
- Container
- The Lancet regional health. Western Pacific
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lanwpc.2022.100452,
title = {Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015-2017): A multicentre prospective study.},
author = {Shi Y and Zhang X and Wu G and Xu J and He Y and Wang D and Huang C and Chen M and Yu P and Yu Y and Li W and Li Q and Hu X and Xia J and Bu L and Yin A and Zhou Y},
year = {2022},
journal = {The Lancet regional health. Western Pacific},
doi = {10.1016/j.lanwpc.2022.100452},
url = {https://doi.org/10.1016/j.lanwpc.2022.100452}
}RIS
TY - JOUR TI - Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015-2017): A multicentre prospective study. AU - Shi Y AU - Zhang X AU - Wu G AU - Xu J AU - He Y AU - Wang D AU - Huang C AU - Chen M AU - Yu P AU - Yu Y AU - Li W AU - Li Q AU - Hu X AU - Xia J AU - Bu L AU - Yin A AU - Zhou Y PY - 2022 JO - The Lancet regional health. Western Pacific DO - 10.1016/j.lanwpc.2022.100452 UR - https://doi.org/10.1016/j.lanwpc.2022.100452 ER -
APA
Y, S., X, Z., G, W., J, X., Y, H., D, W., C, H., M, C., P, Y., Y, Y., W, L., Q, L., X, H., J, X., L, B., A, Y., & Y, Z. (2022). Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015-2017): A multicentre prospective study.. The Lancet regional health. Western Pacific. https://doi.org/10.1016/j.lanwpc.2022.100452
Source records
- pubmed · retrieved 2026-09-27T01:03:22.739Z